Filing Details
- Accession Number:
- 0001415889-23-009403
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-06-07 19:52:39
- Reporting Period:
- 2023-06-05
- Accepted Time:
- 2023-06-07 19:52:39
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1597264 | Blueprint Medicines Corp | BPMC | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1863024 | H. Percy Carter | C/O Blueprint Medicines Corporation 45 Sidney Street Cambridge MA 02139 | Chief Scientific Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-06-05 | 2,307 | $52.06 | 38,117 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with thevesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does notrepresent a discretionary trade by the Reporting Person.
- The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $52.05 to $52.17 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
Billionaire Hedge Funds
